Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9R2D7 | — |
10 year old female patient received a dose of Infanrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 10-year-old female patient who received DTPa (Infanrix) (batch number 9R2D7, expiry date 23-MAY-2025) for prophylaxis. On 31-OCT-2024, the patient received Infanrix. On 31-OCT-2024, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 10 year old female patient received a dose of Infanrix). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-FEB-2025 The Vaccine Administration Facility was the same as Primary Reporter The Certified Medical Assistant called to report that a 10 year old patient received a dose of Infanrix vaccine, which led to inappropriate age at vaccine administration. They wanted to know if the patient needed to receive another dose.